Search - tctmd.com

Displaying 1 - 20 of 84

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Industry News

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

June 18, 2024

News Daily News

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

Yael L. Maxwell

February 15, 2023

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

Caitlin E. Cox

March 21, 2022

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Conference News TCT 2018

The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent

Yael L. Maxwell

September 22, 2018

News Conference News SCAI 2018

PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI

L.A. McKeown

April 26, 2018

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

News Industry News

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

May 25, 2017

News Industry News

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

May 16, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

News Industry News

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

November 29, 2016

Advertisement

What’s Going to Be Hot at TCT 2025

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

No Stents in STEMI? With Careful Selection, Maybe

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

TCTMD’s Top 10 Most Popular Stories for October 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

Top News in Coronary Artery Disease: 2018

The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent

PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content